Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Avacta’s AVA6207 Overcomes Cancer Drug Resistance in Preclinical Studies

Avacta’s AVA6207 Overcomes Cancer Drug Resistance in Preclinical Studies

BitgetBitget2026/11/19 07:13
  • Avacta presented preclinical results today in Barcelona showing AVA6207 reversed resistance to topoisomerase I inhibitors in laboratory studies and animal models.
  • The dual-payload drug achieved complete responses in resistant ovarian and lung tumor models, supporting clinical development in biomarker-defined patient groups.
  • AVA6207 also outperformed Enhertu in a gastric tumor model.
  • Payloads have been selected, with the clinical candidate moving into studies supporting an investigational new drug application in the fourth quarter of 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avacta Group plc published the original content used to generate this news brief on November 19, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A breakthrough after a two-year tug of war! UniCredit and Germany reach a key compromise on the acquisition of Commerzbank, paving the way for the emergence of a $1.4 trillion banking giant

UniCredit and Germany have reached an agreement on major points of contention regarding the acquisition of Commerzbank, marking significant progress in the Italian bank’s two-year-long battle for control over Commerzbank.

智通财经•2026/11/19 07:36

Preventing the Spread of AI Credit Risks! South Korean Financial Regulators Launch Inspections, Requiring Banks and Brokerages to Report AI-Related Exposures

As concerns rise over the risks of massive investments and debt financing in the artificial intelligence (AI) sector, South Korea's financial regulators have requested leading domestic financial institutions to disclose their risk exposure in the AI field.

智通财经•2026/11/19 07:07
Preventing the Spread of AI Credit Risks! South Korean Financial Regulators Launch Inspections, Requiring Banks and Brokerages to Report AI-Related Exposures

Wells Fargo (WFC.US) doubles its IBIT holdings for clients as U.S. institutions significantly increase positions in Q3

According to the 13F report, Wells Fargo's client holdings of IBIT shares have doubled to nearly 50 million shares, equivalent to 30,553 BTC. Institutions such as Goldman Sachs and Bank of America have also significantly increased their holdings of spot bitcoin ETFs. Despite the current bitcoin price falling more than 20% from the quarter-end, institutional enthusiasm for allocation remains strong.

智通财经•2026/11/19 04:02
Wells Fargo (WFC.US) doubles its IBIT holdings for clients as U.S. institutions significantly increase positions in Q3